Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2010
05/18/2010US7718860 Plants and seeds of corn variety CV911339
05/18/2010US7718859 Plants and seeds of corn variety CV391950
05/18/2010US7718856 Inbred maize line PHE2E
05/18/2010US7718855 Inbred corn line SY0705W
05/18/2010US7718854 Cotton variety 04T042
05/18/2010US7718853 Soybean cultivar S07-03JR103829
05/18/2010US7718852 Canola cultivar DN040241
05/18/2010US7718851 transgenic plants for use in generation of human milk proteins in seeds; transforming a monocotyledonous plant with a chimeric gene having a protein-coding sequence encoding a protein normally present in human milk under the control of a seed maturation-specific promoter
05/18/2010US7718850 Methods and means for delaying seed shattering in plants
05/18/2010US7718849 use of tospoviral nucleic acid molecule in transgenic plant for providing high levels of broad-spectrum resistance against homologous and heterologous tospoviruses in plants
05/18/2010US7718848 Safe production of a product of interest in hybrid seeds
05/18/2010US7718847 Using vector transformation to generate sperm cells expressing heterologous gene sequences; producing non-human vertebrate that harbours spermatogonial stem cells
05/18/2010US7718846 Animal models of long QT syndrome and uses thereof
05/18/2010US7718845 Production of growth hormone in the milk of a transgenic bovine and methods of purification of the growth hormone from the milk
05/18/2010US7718790 1st and 2nd primer sets provide a first detectable signal on the occurrence of amplification of mitochondrial nucleic acid and second signal on the occurrence of amplification of host nuclear nucleic acid; probe comprising a 6-carboxyfluorescein reporter, 5-carboxytetramethylrhodamine quencher molecule
05/18/2010US7718789 Compositions and methods for the modification of gene expression
05/18/2010US7718788 genes are differentially expressed in tea plant under drought conditions; polynucleotide is circular in shape
05/18/2010US7718787 Gene families associated with cancers
05/18/2010US7718786 Process for obtaining recombined nucleotide sequences in vitro, libraries of sequences and sequences thus obtained
05/18/2010US7718784 RNA/DNA chimera comprising a fluorophore-quencher pair and a nucleic acid construct; for rapid screening of interactions between the HIV-1 nucleocapsid protein, NCp7, and a stem-loop region, SL3, of the HIV-1 RNA, or antagonists
05/18/2010US7718777 MHC-peptide complex binding ligands
05/18/2010US7718776 Comprises monoclonal antibody which specifically binds osteoprotegerin ligand (OPGL) for diagnosis, prevention and treatment of bone disorders
05/18/2010US7718773 treatment of hyperphosphataemia and cardiovascular diseases or arthritis
05/18/2010US7718763 Substrate polyeptides for von Willebrand factor cleaving protease ADAMTS-13
05/18/2010US7718632 RNAi inhibition of alpha-ENaC expression
05/18/2010US7718629 double-stranded ribonucleic acid comprises a sense strand first sequence and an antisense strand second sequence; modified; as a biodrug for treating diseases caused by Eg5 expression; as anticarcinogenic agent for treating cancer; selectively and efficiently silence the Eg5 gene
05/18/2010US7718628 modified oligonucleotide for gene therapy; as antitumor agent, anticarcinogenic agent; Inhibiting synthesis and function; arresting cellular proliferation
05/18/2010US7718627 Plasmid comprising nucleotide sequences coding immunoglobulin complementary determining regions specific to tumor antigen (5T4); for use in delivering product and/or nucleotide sequences of interest to tumor; drug delivery
05/18/2010US7718626 ErbB3 binding protein compositions and methods of use
05/18/2010US7718623 Immunostimulatory oligonucleotide that induces interferon alpha
05/18/2010US7718617 Using tissue preservation solution ( kallikrein inhibitor ) to decrease reperfusion injury of an organ during surgery and/or following removal of organ
05/18/2010US7718613 Armed peptides
05/18/2010US7718606 Methods for treating muscle diseases and disorders
05/18/2010US7718578 Method of synthesis and testing of combinatorial libraries using microcapsules
05/18/2010US7718575 Method of selecting HLA-DP4 ligands and the applications thereof
05/18/2010US7718445 Using microwave heating to accelerated and give chemical reaction exquisite enzyme-like specificity
05/18/2010US7718432 Non-immunogenic, hydrophilic/cationic block copolymers and uses thereof
05/18/2010US7718431 PUFA polyketide synthase systems and uses thereof
05/18/2010US7718424 AAV4 vector and uses thereof
05/18/2010US7718417 recombinant yeast comprising one or more heterologous nucleic acid molecules encoding an enzyme that converts pyruvate and D-glyceraldehyde 3-phosphate to 1-deoxyxylose 5-phosphate and another that converts 1-deoxy-D-xylulose 5-phosphate to 2-C-methyl-D-erythritol 4-phosphate
05/18/2010US7718413 Secretase for use in identifying modulator for treatment and prevention of alzheimers disease; Beta-site amyloid precursor protein cleaving enzyme (BACE)
05/18/2010US7718410 In vivo incorporation of alkynyl amino acids into proteins in eubacteria
05/18/2010US7718409 Transferring particles through cell barriers; insert cell into electrically conductive fluid, monitor electrical current, adjust voltage to maintain preferential diffusion
05/18/2010US7718403 Amplification and analysis of whole genome and whole transcriptome libraries generated by a DNA polymerization process
05/18/2010US7718401 Expression of HIV polypeptides and production of virus-like particles
05/18/2010US7718400 for increasing insulin sensitivity; decreasing the dose of insulin required for the treatment of diabetes; controlling serum glucose levels; increasing lean tissue mass; increasing overall body strength; and regulating bone resorption
05/18/2010US7718399 Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragment
05/18/2010US7718398 DNA comprising promoter sequence, derived from a wild-type promoter of a methyltrophic yeast, whose transcription efficiency is modulated in comparison to the efficiency of the wild-type promoter by inserting or modifying a DNA binding site
05/18/2010US7718397 Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
05/18/2010US7718396 Inducible high expression system
05/18/2010US7718391 Assays for identifying modulators of rhomboid polypeptides
05/18/2010US7718390 drug screening; identifying potential antiprotozoal agents using the novel kinase
05/18/2010US7718383 Human T2R65 taste receptor and related assays for identifying human bitter taste modulators
05/18/2010US7718382 Method for identifying compounds for treatment of pain
05/18/2010US7718379 Identifying haematopoietic stem cells based on cell surface markers
05/18/2010US7718373 Canola event PV-BNGT04(RT73) and compositions and methods for detection thereof
05/18/2010US7718180 Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
05/18/2010US7718179 Ostertagia vaccine
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010US7718173 Anti-pro6094 antibodies
05/18/2010US7718157 Targeted lipid particles
05/18/2010US7718129 substrate for bioassay in which reaction region serving as a field of mutual reaction between probe material and sample material is formed; bioassaying apparatus and method are adapted for detecting fluorescence produced from fluorescence marking agent existing in the reaction region
05/18/2010US7718072 automated pipettes; for particles suspended in fluid; nucleic acid isolation
05/18/2010US7718048 base sequence detecting electrode, a base sequence detecting device and a base sequence detecting method for specifically detecting a specific gene existing in a sample; precisely carries out detection of current based on an interaction with a target base sequence
05/18/2010CA2557882C Defective packaging non-oncoviral vectors based on mpmv and hiv
05/18/2010CA2422599C Gibberellin 2-oxidase gene, functions and uses thereof
05/18/2010CA2410413C Fluorescent proteins
05/18/2010CA2407287C Method of forming vertebrate pancreas in vitro
05/18/2010CA2404174C Hybridisation beacon and method of rapid sequence detection and discrimination
05/18/2010CA2379023C Metabolically engineered microbial cell with an altered metabolite production
05/18/2010CA2378543C Modified human granulocyte-colony stimulating factor and process for producing same
05/18/2010CA2368965C Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
05/18/2010CA2343171C Oligonucleotides, method and kit for detecting listeria monocytogenes by nucleic acid amplification and/or nucleic acid hybridization
05/18/2010CA2323753C Lipopolysaccharide .alpha.-2,3 sialyltransferase of campylobacter jejuni and its uses
05/18/2010CA2302808C 50 human secreted proteins
05/18/2010CA2266429C Hedgehog interacting proteins and uses related thereto
05/18/2010CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit
05/18/2010CA2231948C Modified phytases
05/18/2010CA2216717C Compositions for the diagnosis, prevention, and treatment of tumor progression
05/18/2010CA2121698C Synthesis of human procollagens and collagens in recombinant dna systems
05/18/2010CA1341605C Synthetic antigen for the detection of aids-related disease
05/17/2010CA2686135A1 Chimeric hirudin proteins
05/15/2010CA2739663A1 Polypeptides that bind trail-r1 and trail-r2
05/14/2010WO2010054377A2 Fully human antibodies against n-cadherin
05/14/2010WO2010054362A2 Temperature-induced polynucleotides and uses therefor
05/14/2010WO2010054348A2 Pathogen-inducible promoters and their use in enhancing the disease resistance of plants
05/14/2010WO2010054328A2 Compositions and methods for the inhibition of cripto/grp78 complex formation and signaling
05/14/2010WO2010054326A2 C-terminal fragments of glucagon-like peptide-1 (glp-1)
05/14/2010WO2010054319A2 Penicillin-g acylases
05/14/2010WO2010054267A1 Immunosuppression compound and treatment method
05/14/2010WO2010054212A1 Engineered antibodies with reduced immunogenicity and methods of making
05/14/2010WO2010054191A1 Genetic loci associated with cell wall digestibility in maize
05/14/2010WO2010054108A2 Cas6 polypeptides and methods of use
05/14/2010WO2010054010A1 Anti-dll4 antibodies and uses thereof
05/14/2010WO2010054004A2 Nucleic acid extraction on curved glass surfaces
05/14/2010WO2010053990A2 Crhr2 peptide agonists and uses thereof
05/14/2010WO2010053867A1 NOVEL At1g67330 GENE INVOLVED IN ALTERED NITRATE UPTAKE EFFICIENCY
05/14/2010WO2010053838A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
05/14/2010WO2010053820A1 Sequence preserved dna conversion
05/14/2010WO2010053636A1 Enhanced production and purification of a natural high intensity sweetener
1 ... 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 ... 4023